Radioprotectors in tumor radiotherapy: factors and settings determining therapeutic ratio
- 1 January 1988
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 39 (1-3) , 179-187
- https://doi.org/10.1016/0163-7258(88)90059-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The effect of 2-[(aminopropyl)amino] ethanethiol (WR1065) on radiation-induced DNA damage and repair and cell progression in V79 cellsBritish Journal of Cancer, 1986
- Protection of acute and late radiation damage of the gastrointestinal tract by WR-2721International Journal of Radiation Oncology*Biology*Physics, 1986
- SHORT COMMUNICATIONCarcinogenesis: Integrative Cancer Research, 1986
- Protection of spermatogonial survival and testicular function by WR-2721 against high and low doses of radiationInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Need for studies on factors that influence radioprotection of solid tumors by wr-2721International Journal of Radiation Oncology*Biology*Physics, 1984
- Effect of tumor type, size, and endpoint on tumor radioprotection by WR-2721International Journal of Radiation Oncology*Biology*Physics, 1984
- Radioprotection by WR-2721 in vitro at low oxygen tensions: Implications for its mechanisms of actionBritish Journal of Cancer, 1983
- Thiol radioprotectionin vivo: the critical role of tissue oxygen concentrationThe British Journal of Radiology, 1981
- Radioprotection of immunologically reactive T lymphocytes by WR-2721International Journal of Radiation Oncology*Biology*Physics, 1978
- Mechanism of Action of Aminothiol RadioprotectorsNature, 1967